Loading company…
Seoul-based biotech company developing diagnostic tools and therapeutic products, founded in 2018.
Founded in 2018 and headquartered in Seoul, South Korea, MX BIO Inc. develops and manufactures diagnostic tools and therapeutic products for healthcare professionals, research institutions and laboratories. Its proprietary assays and kits detect biological markers used in oncology, infectious diseases and genetic testing. CEO Jae Lee has a history of leadership in the biotech sector. The company raised KRW 11.3 billion in Series B funding as of April 21, 2026, and KRW 2.8 billion in Series A funding in March 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in